Atypical fractures femur

Denosumab ( Prolia ) is a human monoclonal antibody ( IgG2 ) that targets and binds with high affinity and...


The FDA ( Food and Drug Administration ) has approved a new indication for Xgeva ( Denosumab ) for the...


Atypical femoral fractures have been reported rarely in patients with postmenopausal osteoporosis receiving long-term ( greater than or equal to...


A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an...